CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

$60K plus car that night vision has never worked. Sway bar actually broke from only road use. Been to dealer 3 times for issues. Cv axle replacement, display screen replacement. Check engine light ...

In a transaction expected to close the first half of the year, Merck, known as MSD outside of the United States and Canada, will be purchasing WuXi Vaccines’ 167,000 square-foot manufacturing plant in ...

With potential passage of the BIOSECURE Act looming and WuXi Biologics seeing its share price and profits decline, the Chinese biopharma contract manufacturing giant is responding with a sizable ...

WuXi Biologics has agreed to sell its vaccine production facility in Ireland to Merck & Co for $500m. The sale, confirmed on 6 January 2025, reflects a shift in WuXi’s business strategy amid evolving ...

PUEBLO, Colo. — SunTrain, a San Francisco company, is designing a method to transport power by rail, moving containerized batteries between solar and wind farms in Colorado to existing rail-served ...

Plant-based diets have soared in popularity as people look for ways to improve their health, reduce their carbon footprint, and consume less (or no) animal products. But while following plant ...

Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's (MRK.N), opens new tab therapy to treat a rare lung condition, marking another ...

Jeep may have ceased production of the Cherokee in 2023, as it was getting somewhat long in the tooth, but it's still one of the most iconic SUV nameplates in America, and a rightfully popular ...

TAHLEQUAH, Okla. (KFOR) — A new agreement between Oklahoma and the Cherokee Nation renews the state’s motor vehicle compact with the Tribe and goes into effect January 1, 2025. The ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial ...